Chlorhexidine release and antibacterial properties of chlorhexidine- incorporated polymethyl methacrylate-based resin cement

N. Hiraishi, C. K.Y. Yiu, N. M. King, Franklin Chi Meng Tay

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

This study evaluated chlorhexidine release from experimental, chlorhexidine-incorporated polymethyl methacrylate (PMMA)-based resin cements prepared from Super-Bond C&B (Sun Medical) and examined the antimicrobial activity against Streptococcus mutans and Enterococcus faecalis. Chlorhexidine diacetate was added into PMMA polymer to obtain chlorhexidine concentration of 0.0, 1.0, 2.0, 3.0, and 4.0 wt %. Chlorhexidine-incorporated, cured resin disks were immersed in distilled water at 37°C for 5 weeks, and the chlorhexidine release was analyzed by high-performance liquid chromatography. The antibacterial effect of freshly mixed resin cements was examined using the agar diffusion test. For the direct contact test, the wells (n = 6) of microtiter plates were coated with cements. The coated wells were aged up to 3 weeks prior to the placement of bacterial suspensions directly on cured cements. The 3.0 and 4.0% chlorhexidine-incorporated cement exhibited chlorhexidine release for 5 weeks; however, more than 98% of chlorhexidine was retained in resin matrix. No release was detected from the 1.0 and 2.0% incorporated cement at 1 week and 2 weeks, respectively. The agar diffusion test failed to detect antibacterial effects against Enterococcus faecalis, whereas the direct contact test revealed the antibacterial effect of 3.0 and 4.0% incorporated cements against each microbe for 2 weeks. The 3.0 and 4.0% chlorhexidine-incorporated resin cement possessed prolonged chlorhexidine release and antibacterial properties for 2 weeks.

Original languageEnglish (US)
Pages (from-to)134-140
Number of pages7
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume94
Issue number1
DOIs
StatePublished - Jul 1 2010

Fingerprint

Resin Cements
Chlorhexidine
Polymethyl Methacrylate
Polymethyl methacrylates
Cements
Resins
Enterococcus faecalis
Agar
High performance liquid chromatography
Sun
Streptococcus mutans
Solar System
Suspensions
Polymers

Keywords

  • Agar diffusion test
  • Antibacterial effects
  • Chlorhexidine
  • Direct contact test
  • HPLC
  • Resin cement

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering

Cite this

@article{7a4da9053ca34aae9edc6c2cd8d7714d,
title = "Chlorhexidine release and antibacterial properties of chlorhexidine- incorporated polymethyl methacrylate-based resin cement",
abstract = "This study evaluated chlorhexidine release from experimental, chlorhexidine-incorporated polymethyl methacrylate (PMMA)-based resin cements prepared from Super-Bond C&B (Sun Medical) and examined the antimicrobial activity against Streptococcus mutans and Enterococcus faecalis. Chlorhexidine diacetate was added into PMMA polymer to obtain chlorhexidine concentration of 0.0, 1.0, 2.0, 3.0, and 4.0 wt {\%}. Chlorhexidine-incorporated, cured resin disks were immersed in distilled water at 37°C for 5 weeks, and the chlorhexidine release was analyzed by high-performance liquid chromatography. The antibacterial effect of freshly mixed resin cements was examined using the agar diffusion test. For the direct contact test, the wells (n = 6) of microtiter plates were coated with cements. The coated wells were aged up to 3 weeks prior to the placement of bacterial suspensions directly on cured cements. The 3.0 and 4.0{\%} chlorhexidine-incorporated cement exhibited chlorhexidine release for 5 weeks; however, more than 98{\%} of chlorhexidine was retained in resin matrix. No release was detected from the 1.0 and 2.0{\%} incorporated cement at 1 week and 2 weeks, respectively. The agar diffusion test failed to detect antibacterial effects against Enterococcus faecalis, whereas the direct contact test revealed the antibacterial effect of 3.0 and 4.0{\%} incorporated cements against each microbe for 2 weeks. The 3.0 and 4.0{\%} chlorhexidine-incorporated resin cement possessed prolonged chlorhexidine release and antibacterial properties for 2 weeks.",
keywords = "Agar diffusion test, Antibacterial effects, Chlorhexidine, Direct contact test, HPLC, Resin cement",
author = "N. Hiraishi and Yiu, {C. K.Y.} and King, {N. M.} and Tay, {Franklin Chi Meng}",
year = "2010",
month = "7",
day = "1",
doi = "10.1002/jbm.b.31633",
language = "English (US)",
volume = "94",
pages = "134--140",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "0021-9304",
publisher = "Heterocorporation",
number = "1",

}

TY - JOUR

T1 - Chlorhexidine release and antibacterial properties of chlorhexidine- incorporated polymethyl methacrylate-based resin cement

AU - Hiraishi, N.

AU - Yiu, C. K.Y.

AU - King, N. M.

AU - Tay, Franklin Chi Meng

PY - 2010/7/1

Y1 - 2010/7/1

N2 - This study evaluated chlorhexidine release from experimental, chlorhexidine-incorporated polymethyl methacrylate (PMMA)-based resin cements prepared from Super-Bond C&B (Sun Medical) and examined the antimicrobial activity against Streptococcus mutans and Enterococcus faecalis. Chlorhexidine diacetate was added into PMMA polymer to obtain chlorhexidine concentration of 0.0, 1.0, 2.0, 3.0, and 4.0 wt %. Chlorhexidine-incorporated, cured resin disks were immersed in distilled water at 37°C for 5 weeks, and the chlorhexidine release was analyzed by high-performance liquid chromatography. The antibacterial effect of freshly mixed resin cements was examined using the agar diffusion test. For the direct contact test, the wells (n = 6) of microtiter plates were coated with cements. The coated wells were aged up to 3 weeks prior to the placement of bacterial suspensions directly on cured cements. The 3.0 and 4.0% chlorhexidine-incorporated cement exhibited chlorhexidine release for 5 weeks; however, more than 98% of chlorhexidine was retained in resin matrix. No release was detected from the 1.0 and 2.0% incorporated cement at 1 week and 2 weeks, respectively. The agar diffusion test failed to detect antibacterial effects against Enterococcus faecalis, whereas the direct contact test revealed the antibacterial effect of 3.0 and 4.0% incorporated cements against each microbe for 2 weeks. The 3.0 and 4.0% chlorhexidine-incorporated resin cement possessed prolonged chlorhexidine release and antibacterial properties for 2 weeks.

AB - This study evaluated chlorhexidine release from experimental, chlorhexidine-incorporated polymethyl methacrylate (PMMA)-based resin cements prepared from Super-Bond C&B (Sun Medical) and examined the antimicrobial activity against Streptococcus mutans and Enterococcus faecalis. Chlorhexidine diacetate was added into PMMA polymer to obtain chlorhexidine concentration of 0.0, 1.0, 2.0, 3.0, and 4.0 wt %. Chlorhexidine-incorporated, cured resin disks were immersed in distilled water at 37°C for 5 weeks, and the chlorhexidine release was analyzed by high-performance liquid chromatography. The antibacterial effect of freshly mixed resin cements was examined using the agar diffusion test. For the direct contact test, the wells (n = 6) of microtiter plates were coated with cements. The coated wells were aged up to 3 weeks prior to the placement of bacterial suspensions directly on cured cements. The 3.0 and 4.0% chlorhexidine-incorporated cement exhibited chlorhexidine release for 5 weeks; however, more than 98% of chlorhexidine was retained in resin matrix. No release was detected from the 1.0 and 2.0% incorporated cement at 1 week and 2 weeks, respectively. The agar diffusion test failed to detect antibacterial effects against Enterococcus faecalis, whereas the direct contact test revealed the antibacterial effect of 3.0 and 4.0% incorporated cements against each microbe for 2 weeks. The 3.0 and 4.0% chlorhexidine-incorporated resin cement possessed prolonged chlorhexidine release and antibacterial properties for 2 weeks.

KW - Agar diffusion test

KW - Antibacterial effects

KW - Chlorhexidine

KW - Direct contact test

KW - HPLC

KW - Resin cement

UR - http://www.scopus.com/inward/record.url?scp=77954111691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954111691&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.31633

DO - 10.1002/jbm.b.31633

M3 - Article

C2 - 20524187

AN - SCOPUS:77954111691

VL - 94

SP - 134

EP - 140

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 0021-9304

IS - 1

ER -